The Covid 19 Epidemic In China

This book contains an in-depth quantitative analysis of the development of the COVID-19 epidemic in China from its very beginning in December 2019 to early April 2020 when it was brought under control. It begins with adjustments of the official cumulative data on newly confirmed cases and deaths, removing any inconsistencies and smoothing the surges not attributable directly to the COVID-19 virus itself. It discusses the measures undertaken by the Chinese Government to control the epidemic. It examines the extent of the infection, the case mortality, and the costs to the Chinese economy in both Hubei, the province in which the first confirmed case was discovered, and the rest of the Mainland outside of Hubei. There is also an international comparison of the Chinese experience with those of other countries.

This book contains an in-depth quantitative analysis of the development of the COVID-19 epidemic in China from its very beginning in December 2019 to early April 2020 when it was brought under control. It begins with adjustments of the official cumulative data on newly confirmed cases and deaths, removing any inconsistencies and smoothing the surges not attributable directly to the COVID-19 virus itself. It discusses the measures undertaken by the Chinese Government to control the epidemic. It examines the extent of the infection, the case mortality, and the costs to the Chinese economy in both Hubei, the province in which the first confirmed case was discovered, and the rest of the Mainland outside of Hubei. There is also an international comparison of the Chinese experience with those of other countries.

The emergence of severe acute respiratory syndrome (SARS) in late 2002 and 2003 challenged the global public health community to confront a novel epidemic that spread rapidly from its origins in southern China until it had reached more than 25 other countries within a matter of months. In addition to the number of patients infected with the SARS virus, the disease had profound economic and political repercussions in many of the affected regions. Recent reports of isolated new SARS cases and a fear that the disease could reemerge and spread have put public health officials on high alert for any indications of possible new outbreaks. This report examines the response to SARS by public health systems in individual countries, the biology of the SARS coronavirus and related coronaviruses in animals, the economic and political fallout of the SARS epidemic, quarantine law and other public health measures that apply to combating infectious diseases, and the role of international organizations and scientific cooperation in halting the spread of SARS. The report provides an illuminating survey of findings from the epidemic, along with an assessment of what might be needed in order to contain any future outbreaks of SARS or other emerging infections.

This book aims to examine the multiple effects of the COVID-19 pandemic on China-Southeast Asia relations from both Chinese and Southeast Asian perspectives. It invites many officials and scholars from the leading think-tanks and famous universities in China and Southeast Asian states to contribute and tries to reveal how has China-Southeast Asia relations been reshaping during/after the COVID-19 pandemic and discuss what kind of measures could be taken to push forward China-Southeast Asia relations and thus ensuring the peace and prosperity in the region. The main content of this book is divided into 10 parts, in which the first chapter briefly introduces the COVID-19 situation in China and Southeast Asia, China’s anti-COVID efforts, and the impacts of the COVID-19 on China-Southeast Asia relations from Chinese and Southeast Asian perspectives. Chapter 2 examines the dual influence of the pandemic on the construction of China-ASEAN community of a shared future and gave some useful policy recommendations on improving China-Southeast Asia relations. The following 8 chapters go deep into the Southeast Asian states’ response to COVID-19 and the economic, political and social effects of the COVID-19 on Southeast Asia–China relations, and look forward the future development of such relations. In addition, it also analyzes Southeast states’ reactions to the intense Sino-US power rivalry during/after the COVID-19 pandemic. This book is probably the first comprehensive study that investigates the impacts of the COVID-19 pandemic on China–Southeast Asia relations from both Chinese and Southeast Asian perspectives. It would not only open up a new area of study on China and Southeast Asia relations, but provide insightful observations and useful information for governments, companies and social organizations to facilitate cooperation in trade and investment, public health, and people-to-people exchanges. Therefore, the intended readership not only includes the academics but also officials, businessmen, journalists and social activists. The most important feature of this book is that it points out China–Southeast Asia relations would be reshaped by COVID-19 in the long run and analyzes how it would be reshaped. It also shows a well-balanced view on the COVID-19 and China–Southeast Asia relations as both university scholars, think-tank experts and government officials are involved in this book.

"Dali L. Yang's Fateful Choices offers a penetrating study of China's management of the COVID-19 outbreak in Wuhan, a momentous event that has reverberated globally as the severe pandemic in a century. Yang's work sheds light on the advantage Chinese health decision-makers had, including access to the novel coronavirus's genomic sequences from several laboratories, as early as the end of December 2019. It was at this time that an emergency action program was initiated to combat the burgeoning outbreak in Wuhan"--

A new strain of coronavirus emerged sometime in November 2019, and within weeks a cluster of patients began to be admitted to hospitals in Wuhan with severe pneumonia, most of them linked to the Huanan Seafood Wholesale Market. China's seemingly effective containment of the first stage of the epidemic, in glaring contrast with the uncontrolled spread in Europe and the United States, was heralded as a testament to the Chinese Communist Party's unparalleled command over the biomedical sciences, population, and economy. Conversely, much academic and public debate about the origins of the virus focuses on the supposedly "backwards" cultural practice of consuming wild animals and the perceived problem of authoritarianism suppressing information about the outbreak until it was too late. The Origins of COVID-19, by Li Zhang, shifts debate away from narrow cultural, political, or biomedical frameworks, emphasizing that we must understand the origins of emerging diseases with pandemic potential (such as SARS and COVID-19) in the more complex and structural entanglements of state-making, science and technology, and global capitalism. She argues that both narratives, that of China's victory and the racist depictions of its culpability, do not address—and even aggravate—these larger forces that degrade the environment and increase the human-wildlife interface through which novel pathogens spill over into humans and may rapidly expand into global pandemics.

The 2019 novel Corona Virus, now COVID-19, stole global headlines in the opening months of 2020, and its many impacts are still to play out. The common adage, “If the US sneezes, the world catches a cold” is now demonstrable in a multiplicity of ways, but it is China that has sneezed. This anthology provides insight into the nature of global pandemics such as SARS, MERS, Ebola and HIV/AIDs, then focuses on Wuhan, where COVID-19 broke out -- though patient zero is as yet unknown. It examines the massive effort that China has undertaken since the outbreak to contain its spread, and includes personal stories of the first lockdown experiences. But the impact may be even more grave on the global economy than it is on global health. National and international analysts address the economic impact both within China’s industrial heartland and on global business, as borders close, entire regions are on lockdown, world airlines cancel flights, major US corporations in China shut their doors, factory floors empty. and global supply chains break down, millions lose their jobs and small businesses tank.. Stocks and the prices of gold and oil are impacted. Soon after the COVID-19 outbreak was announced and the extraordinary quarantine response by China was effected, it was learned that Event 201, a global coronavirus pandemic simulation was held just months earlier, in which a global coronavirus pandemic killed 65 million people. Many questions arise concerning BIg Pharma's push for vaccines, and the mainstream dismissal of the possibility of alternative treatments such as HCQ. Other disturbing questions have arisen: Has the disruption been overblown to inflict damage on China as part of a trade war? On the United States, which faces massive damage to its economy in the midst of an increasingly bitter political divide? What are the biowarfare implications –in the Wuhan instance, where China’s first BSL-4 level laboratory is situated, or in the future in general, given the spread of BSL-4 level laboratories worldwide and most extensively the US, as states and private entities conduct research into germ warfare, including the use of bat-generated viruses, for both offensive and defensive purposes, putting the entire world at risk of accidental leakage or worse? Is this truly a pandemic -- or is it a plandemic, and if so, to what end? What are the likely consequences, intended and not.